Efficacy and Safety of Pemafibrate Extended-Release Tablet: a Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group Comparison Trial
Journal of Atherosclerosis and Thrombosis（2024）
Key words
Extended release,Pemafibrate,Remnants,Selective PPAR alpha modulator,Triglycerides
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined